We conducted a systematic review and meta-analysis of the benefits and risks associated with the use of various pharmacotherapies for the achievement of abstinence, the promotion of cessation or reduction of cannabis use, and retention among individuals with cannabis use disorder (CUD).
KQ1: What are the benefits and harms of pharmacotherapy for cannabis use disorder?
KQ2: Are there known subpopulations for whom currently used pharmacotherapy is most/least effective for cannabis use disorder?
Kondo K, Morasco B, Nugent S, et al. Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review. Annals of Internal Medicine. Published online March 3, 2020. DOI: 10.7326/M19-1105.